BARCELONA -- Good outcomes were the rule, not the exception, for select patients undergoing microwave ablation of peripheral lung nodules, results of a single-center study indicated. Among 52 patients ...
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical ...
Creo Medical (($GB:CREO)) announced an update on their ongoing clinical study. The clinical study titled ‘Assessment of the Safety and Performance ...
Imricor Medical Systems, Inc. ( Company or Imricor) ( ASX: IMR ), together with Amsterdam University Medical Centre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results